These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 8148524)
41. [Tumor size and histological grading of stage 1 breast cancer. Prognostic and therapeutic significance]. Gundersen S; Bøhler P; Hannisdal E; Høst H Tidsskr Nor Laegeforen; 1996 Jan; 116(2):222-5. PubMed ID: 8633328 [TBL] [Abstract][Full Text] [Related]
42. Correlation of E-cadherin expression with clinicopathological parameters in breast carcinoma. Cobanoglu U; Ersoz S; Turgutalp H; Reis A; Ozoran Y Saudi Med J; 2004 Aug; 25(8):1024-7. PubMed ID: 15322592 [TBL] [Abstract][Full Text] [Related]
43. Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay. Bièche I; Noguès C; Paradis V; Olivi M; Bedossa P; Lidereau R; Vidaud M Clin Cancer Res; 2000 Feb; 6(2):452-9. PubMed ID: 10690523 [TBL] [Abstract][Full Text] [Related]
44. Understanding the molecular basis of histologic grade. Ignatiadis M; Sotiriou C Pathobiology; 2008; 75(2):104-11. PubMed ID: 18544965 [TBL] [Abstract][Full Text] [Related]
45. Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy: results of a retrospective analysis. Debled M; MacGrogan G; Brouste V; Mathoulin-Pelissier S; Durand M; Mauriac L Cancer; 2007 Jun; 109(11):2197-204. PubMed ID: 17450590 [TBL] [Abstract][Full Text] [Related]
46. Recurrence in breast cancer. Analysis with frailty model. Gohari MR; Mahmoudi M; Mohammed K; Pasha E; Khodabakhshi R Saudi Med J; 2006 Aug; 27(8):1187-93. PubMed ID: 16883450 [TBL] [Abstract][Full Text] [Related]
47. Prognostic relevance of three histological grading methods in breast cancer. Latinovic L; Heinze G; Birner P; Samonigg H; Hausmaninger H; Kubista E; Kwasny W; Gnant M; Jakesz R; Oberhuber G; Int J Oncol; 2001 Dec; 19(6):1271-7. PubMed ID: 11713599 [TBL] [Abstract][Full Text] [Related]
48. Relationship of tumor grade to other pathologic features and to treatment outcome of patients with early stage breast carcinoma treated with breast-conserving therapy. Nixon AJ; Schnitt SJ; Gelman R; Gage I; Bornstein B; Hetelekidis S; Recht A; Silver B; Harris JR; Connolly JL Cancer; 1996 Oct; 78(7):1426-31. PubMed ID: 8839547 [TBL] [Abstract][Full Text] [Related]
49. [Prognostic factors and therapeutic strategy of breast cancer]. Namer M; Ramaioli A; Hery M; Ferrero JM Rev Prat; 1998 Jan; 48(1):45-51. PubMed ID: 9781209 [TBL] [Abstract][Full Text] [Related]
50. An evaluation of ductal carcinoma in-situ of breast and its correlation with the grade of associated invasive component. Konar K; Chatterjee U; Dutta SK Indian J Pathol Microbiol; 2001 Jul; 44(3):297-300. PubMed ID: 12024916 [TBL] [Abstract][Full Text] [Related]
51. p27(Kip1) expression and grading of breast cancer diagnosed on cytological samples. Troncone G; Migliaccio I; Caleo A; Palmieri EA; Iaccarino A; Sparano L; Vetrani A; Palombini L Diagn Cytopathol; 2004 Jun; 30(6):375-80. PubMed ID: 15176022 [TBL] [Abstract][Full Text] [Related]
52. Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers? Sinha PS; Bendall S; Bates T Eur J Surg Oncol; 2000 Dec; 26(8):733-7. PubMed ID: 11087636 [TBL] [Abstract][Full Text] [Related]
53. Pathological classification and grading of primary ovarian carcinoma: experience of the ARTAC ovarian study group. Vacher-Lavenu MC; Le Tourneau A; Duvillard P; Godefroy N; Pinel MC Bull Cancer; 1993 Feb; 80(2):135-41. PubMed ID: 8173164 [TBL] [Abstract][Full Text] [Related]
54. Correlation between histological grade and c-erbB2 oncoprotein overexpression in infiltrating ductal carcinoma of breast. Looi LM; Cheah PL; Yap SF Malays J Pathol; 1997 Jun; 19(1):35-9. PubMed ID: 10879240 [TBL] [Abstract][Full Text] [Related]
55. Correlation of nuclear morphometry of breast cancer in histological sections with clinicopathological features and prognosis. Abdalla F; Boder J; Markus R; Hashmi H; Buhmeida A; Collan Y Anticancer Res; 2009 May; 29(5):1771-6. PubMed ID: 19443402 [TBL] [Abstract][Full Text] [Related]
56. Comparison of the prognostic significance of current and modified histological grades in breast carcinomas. Charpin C; Bacquie N; Bouvier C; Devictor B; Boulat J; Andrac L; Lavaut MN; Allasia C; Piana L Anticancer Res; 1995; 15(6B):2611-7. PubMed ID: 8669834 [TBL] [Abstract][Full Text] [Related]
57. Prognosis of radically operated breast carcinoma patients. A retrospective study of 167 consecutive patients with emphasis on histopathological grading, reproducibility and mean nuclear area. Raabe NK; Schistad O; Sauer T; Bofin A; Kaaresen R; Fossaa SD APMIS; 1997 May; 105(5):363-70. PubMed ID: 9201237 [TBL] [Abstract][Full Text] [Related]
58. Grading systems in the cytological diagnosis of breast cancer: a review. Bansal C; Pujani M; Sharma KL; Srivastava AN; Singh US J Cancer Res Ther; 2014; 10(4):839-45. PubMed ID: 25579516 [TBL] [Abstract][Full Text] [Related]
59. Correlative Evaluation of Seven Cytological 3-Tier Grading Systems of Breast Carcinoma with the Standard Histological Grading: A 4 and ½ Year Study. Pai S; Murthy V S Acta Cytol; 2023; 67(5):482-492. PubMed ID: 37331335 [TBL] [Abstract][Full Text] [Related]
60. [Prospective study of cytoprognosis in breast carcinoma. Correlation between the cytological and histological grading]. Stosiek U; Breitbach GP; Wolfmüller H Pathologe; 1983 May; 4(3):130-4. PubMed ID: 6348727 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]